Price movement over the last 24 hours
Align Technology, Inc. vs Invesco DB Oil Fund — how do they compare? Align Technology, Inc. trades at $176.3 (market cap $13.27B), while Invesco DB Oil Fund trades at $18.74. Which is the better fit depends on your goals.
| ALGN | DBO | |
|---|---|---|
Market Cap | $13.27B | — |
Sector | Health | Commodities - Energy |
52-Week High | $207.19 | $23.80 |
52-Week Low | $124.88 | $11.98 |
Enterprise Value | $12.32B | — |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
DBO trades at $17.34 with a modest 0.35% daily gain amid bearish technical signals. The stock shows mixed momentum with oversold RSI readings but faces strong resistance at $18. Recent oil price volatility driven by Middle East tensions and supply disruptions creates both opportunities and risks for energy sector stocks.
The outlook remains cautious with technical indicators favoring bearish momentum, though oversold conditions suggest potential for near-term stabilization. Investment opportunity exists if geopolitical tensions sustain higher oil prices, but risks include supply growth and demand uncertainty that could pressure energy stocks further.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →